Neo Ivy Capital Management Takes $472,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Neo Ivy Capital Management bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,770 shares of the company’s stock, valued at approximately $472,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. CWM LLC raised its position in HealthEquity by 6.9% in the 2nd quarter. CWM LLC now owns 3,958 shares of the company’s stock worth $341,000 after purchasing an additional 255 shares during the period. SG Americas Securities LLC boosted its holdings in HealthEquity by 48.5% during the 2nd quarter. SG Americas Securities LLC now owns 3,798 shares of the company’s stock valued at $327,000 after acquiring an additional 1,241 shares during the period. Wealth Enhancement Advisory Services LLC bought a new position in HealthEquity in the 2nd quarter valued at $265,000. Gradient Investments LLC increased its stake in HealthEquity by 2.3% in the second quarter. Gradient Investments LLC now owns 54,849 shares of the company’s stock worth $4,728,000 after purchasing an additional 1,218 shares during the period. Finally, Raymond James & Associates lifted its position in shares of HealthEquity by 11.3% during the second quarter. Raymond James & Associates now owns 149,407 shares of the company’s stock worth $12,879,000 after purchasing an additional 15,140 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 2.1 %

HealthEquity stock opened at $97.36 on Thursday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The stock has a market cap of $8.50 billion, a PE ratio of 81.13, a price-to-earnings-growth ratio of 1.57 and a beta of 0.55. The stock has a 50-day moving average of $93.48 and a two-hundred day moving average of $84.00. HealthEquity, Inc. has a one year low of $62.10 and a one year high of $105.82.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. The trade was a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 18,786 shares of company stock valued at $1,722,387 in the last three months. 2.20% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages recently weighed in on HQY. BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Royal Bank of Canada boosted their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday. Barrington Research raised their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.